CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.90 +0.06 (+6.75%)
At close: Oct 1, 2026 · 4:00 PM EDT

CytoMed Therapeutics (GDTC) Operating Leases (2021 - 2026)

Updated

CytoMed Therapeutics' Operating Leases was $41,249 in Q4 2025, up 138.3% from $17,312 a year earlier.

Analysis

CytoMed Therapeutics (GDTC) Operating Leases (2021 - 2026) Analysis & Trends

At the end of FY2025, Operating Leases at CytoMed Therapeutics came in at $19,598, up 137.2% from FY2024.

  • Operating Leases shows a four-year compound annual growth rate of 25.8% (FY2021 to FY2025).
  • In earlier years, Operating Leases was $8,262 in FY2024 (+30.6%), $6,324 in FY2023 (-18.0%), $7,710 in FY2022 (-1.3%) and $7,813 in FY2021.
  • The Q4 2025 figure marks the highest quarterly Operating Leases in data going back to Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 CytoMed Therapeutics 9.94 Mn -1.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20,574.00
Dec 31, 2025 41,249.33
Jun 30, 2025 19,571.00
Dec 31, 2024 17,311.91
Jun 30, 2024 112.00
Dec 31, 2023 6,324.00
Jun 30, 2023 298.00
Dec 31, 2022 4,834.25
Dec 31, 2021 11,287.67
API Access

CytoMed Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=GDTC&period=max&api_key=YOUR_API_KEY